Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
Learn more about this new series with SSO President, Dr. Ronald DeMatteo, providing quick updates on important SSO initiatives through interviews with variou…
Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
Results from the phase I TROPION-PanTumor01 trial showed that the antibody-drug conjugate datopotamab deruxtecan was active in patients with locally advanced or metastatic hormone receptor…
Convergence Science | Cancer Research | American Association for Cancer Research .aacrcontent { display: flex; flex-direction: row; justify-content: space-between; align-items: stretch; } .intro { margin-top:…
During a Case-Based Roundtable® event, Ruth M. O’Regan, MD, led a discussion on whether to order next-generation sequencing and/or circulating tumor DNA testing for a…
Learn about the rates of new cases, survival, and deaths from colorectal cancer in the U.S. This video also describes the symptoms and risk factors…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Setanaxib plus pembrolizumab improved progression-free survival and overall survival in recurrent or metastatic head and neck squamous cell carcinoma.
Brandon Mahal, MD, of Sylvester Comprehensive Cancer Center, was commissioned to write a collaborative article on prostate cancer for The Lancet.
A new study suggests that individuals who are obese or are tall and carry fat in their midsection have a higher risk of developing colorectal…